Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,978 | 601 | 99.0% |
| Education | $97.28 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,845 | 167 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,135 | 94 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $793.01 | 43 | $0 (2024) |
| GENZYME CORPORATION | $675.38 | 36 | $0 (2024) |
| Amgen Inc. | $674.16 | 38 | $0 (2024) |
| UCB, Inc. | $504.84 | 30 | $0 (2024) |
| Lilly USA, LLC | $499.50 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $448.95 | 25 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $394.02 | 18 | $0 (2024) |
| PFIZER INC. | $278.63 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,644 | 88 | ABBVIE INC. ($323.13) |
| 2023 | $1,513 | 89 | ABBVIE INC. ($507.11) |
| 2022 | $1,902 | 108 | ABBVIE INC. ($646.31) |
| 2021 | $1,379 | 90 | AbbVie Inc. ($456.12) |
| 2020 | $931.55 | 67 | AbbVie Inc. ($225.53) |
| 2019 | $1,129 | 60 | AbbVie, Inc. ($349.28) |
| 2018 | $660.36 | 46 | AbbVie, Inc. ($127.17) |
| 2017 | $916.82 | 55 | AbbVie, Inc. ($210.06) |
All Payment Transactions
603 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: WOUND CARE | ||||||
| 12/13/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: WOUND CARE | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.79 | General |
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: Immunology | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: Immunology | ||||||
| 11/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: WOUND CARE | ||||||
| 10/29/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Immunology | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: WOUND CARE | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.75 | General |
| 09/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 6,385 | 11,805 | $1.3M | $592,026 |
| 2022 | 28 | 5,743 | 10,710 | $1.4M | $617,963 |
| 2021 | 35 | 6,851 | 15,414 | $2.1M | $855,970 |
| 2020 | 33 | 7,088 | 14,645 | $2.3M | $893,376 |
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,307 | 2,047 | $225,170 | $124,972 | 55.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 899 | 1,226 | $183,900 | $83,805 | 45.6% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 126 | 152 | $185,592 | $73,977 | 39.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 966 | 1,353 | $115,005 | $49,745 | 43.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 177 | 269 | $56,490 | $33,376 | 59.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 368 | 677 | $57,545 | $26,123 | 45.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 154 | 217 | $54,250 | $23,644 | 43.6% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 109 | 163 | $48,085 | $22,010 | 45.8% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 48 | 65 | $39,000 | $21,166 | 54.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 871 | 3,934 | $39,340 | $19,038 | 48.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 169 | 190 | $25,650 | $15,291 | 59.6% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 30 | 34 | $40,800 | $15,225 | 37.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 319 | 349 | $38,390 | $13,299 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 155 | 155 | $21,700 | $12,016 | 55.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 255 | 412 | $21,740 | $10,861 | 50.0% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 64 | 83 | $30,540 | $10,137 | 33.2% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 52 | 69 | $20,120 | $9,467 | 47.1% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 15 | 21 | $9,450 | $6,293 | 66.6% |
| 69100 | Biopsy of ear | Office | 2023 | 87 | 98 | $25,480 | $5,166 | 20.3% |
| 17273 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 23 | 28 | $9,660 | $4,171 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 33 | $5,280 | $2,975 | 56.4% |
| 17283 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 13 | 13 | $6,240 | $2,246 | 36.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 33 | 33 | $4,785 | $1,720 | 35.9% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 34 | 34 | $4,250 | $1,717 | 40.4% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 13 | 14 | $3,360 | $1,252 | 37.3% |
About Dr. Charles Kovaleski, MD
Dr. Charles Kovaleski, MD is a Dermatology healthcare provider based in Panama City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811972391.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Kovaleski, MD has received a total of $10,075 in payments from pharmaceutical and medical device companies, with $1,644 received in 2024. These payments were reported across 603 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($9,978).
As a Medicare-enrolled provider, Kovaleski has provided services to 26,067 Medicare beneficiaries, totaling 52,574 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Panama City, FL
- Active Since 12/07/2005
- Last Updated 05/28/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1811972391
Products in Payments
- SKYRIZI (Biological) $1,266
- DUPIXENT (Biological) $930.79
- RINVOQ (Biological) $693.14
- COSENTYX (Biological) $679.61
- Humira (Biological) $566.73
- TALTZ (Drug) $476.47
- Otezla (Drug) $363.52
- Enbrel (Biological) $342.38
- LIBTAYO (Biological) $323.56
- TREMFYA (Drug) $305.84
- EUCRISA (Drug) $266.76
- Cimzia (Drug) $255.83
- Bimzelx (Biological) $249.01
- HUMIRA (Biological) $185.30
- COSENTYX (Drug) $185.18
- BLU-U (Medical Supply) $173.64
- Sotyktu (Drug) $151.91
- ILUMYA (Biological) $140.40
- DUPIXENT DUPILUMAB INJECTION (Biological) $119.57
- ENSTILAR (Drug) $106.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Panama City
Dr. Jon Ward, Md, MD
Dermatology — Payments: $15,137
Robert Siragusa, Md, MD
Dermatology — Payments: $8,886
Alexander Davis, Md, MD
Dermatology — Payments: $4,724
Dr. Christopher Wolfe, Do, DO
Dermatology — Payments: $2,755